Ameluz is aminolevulinic acid 10% gel, a photosensitizing agent that's used to treat actinic keratoses (AK) (sun spots) in adults. Your provider will apply Ameluz (aminolevulinic acid) to the spots on the skin at their office or clinic. Afterwards, they'll use red light photodynamic therapy (PDT) to activate the medication to destroy the cells that cause AK. The most common side effects of Ameluz (aminolevulinic acid) include redness and pain around the treated skin areas.
Mild-to-moderate actinic keratoses on the face and scalp (in combination with photodynamic therapy)
Ameluz (aminolevulinic acid) is a photosensitizing agent. It's activated ("turned on") by light and kills skin cells that cause actinic keratoses.
Source: DailyMed
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report to your care team if they continue or are bothersome):
Only needs one or two treatments
Many people had clear skin 3 months after the first treatment
After medication is applied, only need to wait 3 hours before PDT (compared to 14 to 18 hours with Levulan)
Only approved to treat AK on the face and scalp, not arms or hands
Not a good option for people allergic to soybeans
Must avoid sunlight or bright indoor light for about 48 hours after treatment
Make sure to bring a wide-brimmed hat to your appointment so you can protect the treated areas from the sun or bright indoor light after you leave. You'll need to avoid light for about 2 days to minimize burning and stinging in these areas.
If, for whatever reason, you're not able to receive light therapy after Ameluz (aminolevulinic acid) is applied, let your provider know. They'll ask you to wash off the gel with saline and water. You'll still need to protect the treated areas from light for about 2 days.
Some medications, such as certain antibiotics or acne medication, can make your skin even more sensitive to sunlight during treatment with Ameluz (aminolevulinic acid). Tell your provider all of the medications you're taking so they can check if they're safe to take with Ameluz (aminolevulinic acid).
After treatment with Ameluz (aminolevulinic acid), you can expect some skin reddening, scabbing, and pain at the application site. These side effects are temporary and should only last for up to 4 days for most people. But sometimes, they can last 2 weeks or longer. If anything concerns you, call your provider to discuss.
If your sun spots don't go away within 3 months, contact your provider. You might need another treatment with Ameluz (aminolevulinic acid).
It isn't known if Ameluz (aminolevulinic acid) causes harm to unborn babies or breastfed babies. If you're pregnant or breastfeeding, discuss the risks and benefits for you and your baby with your provider.
Ameluz (aminolevulinic acid) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Though rare, Ameluz (aminolevulinic acid) can cause serious allergic reactions, including life-threatening reactions like anaphylaxis (e.g., closing of the throat). If you experience trouble breathing, swelling of your lips, tongue, or face, or rash after treatment with Ameluz (aminolevulinic acid), get emergency medical help right away.
Some people have reported temporary memory problems after using Ameluz (aminolevulinic acid) with photodynamic therapy (PDT), but this isn't common. If you feel confused or have trouble remembering things after your treatment, contact your provider.
Risk factors: Taking medications that make your skin more sensitive to light
Ameluz (aminolevulinic acid) makes your skin more sensitive to light. Your risk for skin damage from light exposure is higher if you're taking other medications that make your skin more sensitive to light. After getting treatment with Ameluz (aminolevulinic acid), avoid sunlight, tanning beds, and bright indoor light for 2 days, even if you aren't exposed to light therapy.
You can protect the treated areas of your skin by wearing a wide-brimmed hat. Doing so can help prevent stinging, burning, irritation, and swelling at the treatment sites on your skin. Keep in mind that wearing sunscreen won't protect your skin from visible light.
The special lamps used for light therapy after treatment with Ameluz (aminolevulinic acid) can cause eye irritation or injury. Your provider will ask you to wear protective eyewear while you're getting light therapy to protect your eyes. Never stare directly into the lamp while it's on.
Ameluz (aminolevulinic acid) can also cause swelling of your eyelids, as well as irritation to other sensitive skin areas, such as the nose and mouth. Your provider will take care to not get this medication in your eyes or to other sensitive areas. But if they do on accident, you'll need to rinse the area with water as soon as possible.
Risk factors: Taking blood thinners | Bleeding problems
Ameluz (aminolevulinic acid) hasn't been well-studied in people with bleeding conditions. Let your provider know if you're taking blood-thinning medications (e.g., warfarin (Coumadin)) or if you have a history of bleeding problems. If any of the AK spots have bleeding or broken skin, your provider might not be able to treat you with Ameluz (aminolevulinic acid) until they're healed.
Ameluz is made up of aminolevulinic acid 10% topical gel.
Adults: Ameluz (aminolevulinic acid) is applied to the sun spots (on the scalp or face only) by a healthcare provider at their clinic. Your provider will cover the treated area and let the medication absorb into the skin for 3 hours. Afterwards, you'll receive photodynamic therapy (PDT) with the BF-RhodoLED or RhodoLED XL lamp for about 10 minutes.
If needed, your provider can treat the spots again after 3 months.
Porphyria (a genetic condition where your body has problems making a protein called heme)
Allergies to porphyrins or soybean phosphatidylcholine (a component of soybeans)
Mild-to-moderate actinic keratoses on the face and scalp (in combination with photodynamic therapy)
Minimally to moderately thick actinic keratoses of the face, scalp, or arms and hands (in combination with photodynamic therapy)
Actinic keratoses (AK) in adults
By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.
American Cancer Society. (2021). Getting photodynamic therapy.
Biofrontera Inc. (2023). Ameluz- aminolevulinic acid hydrochloride gel [package insert]. DailyMed.
Lehmann, P., et al. (2011). Photodermatoses: Diagnosis and treatment. Deutsches Ärzteblatt International.
Malcolm, E. (2020). What are porphyrins and how are they connected to porphyria? Porphyria News.
MedlinePlus. (2009). Porphyria.
National Institute of Diabetes and Digestive and Kidney Diseases. (2020). Porphyria.
Nestor, M. S., et al. (2019). Safety and efficacy of aminolevulinic acid 10% topical gel versus aminolevulinic acid 20% topical solution followed by blue-light photodynamic therapy for the treatment of actinic keratosis on the face and scalp: A randomized, double-blind study. The Journal of Clinical and Aesthetic Dermatology.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.